She claimed Oramed data would define new standard for diabetes and ORMp was clear winner over Afrezza yet on a market cap to market cap comparison and lead time and actual completed trials with FDA PDUFA date for MNKD only 2 1/2 months away and ORMP 5 yrs away if it makes it that far once they actually release full data and actually do,long term trials on 100's and 1000's of patients as MNKD has, her claims clearly were a fabrication to pump PPS up to maximize profits when her and her cronies likely dumped yesterday or this morning. Look at the PPS now ! Hardly a stock defining new standard for,diabetes and likely will end up,like all the other now penny stocks that failed at developing an oral insulin pill as wildbill pointed out in his comment to her article which she did not even try to dispute just like never disputing all the comments proving her exubera and Afrezza analogy was totally false. The only thing clear is she pulled a pump,and dump and many here are going to likely lose on this pig with lipstick.
she express an opinion just like you express your crybaby opinion, one days trading action isn't a LONG TERM Definition of how successful these pills will be, looked like too much anticipation for BIG NEWS but only came up with the phase 2 trial success- from $8 bucks in December I'm ok with- I like the Buffett quote of how the stock market in the short term s like a voting machine but in the long term a weighing machine- you act like its all over but if you don't have the stomach you need to quit.
Sentiment: Strong Buy
Did you read the comments to her article , she obviously was dishing dirt of her own as you do now. Not one response from her to any of the comments that clearly prove she is a farce. I suggest you read all comments especially one by wildbill investor which has all kinds of interesting facts about ORMP and EMIS, GNBT. The mother of ORMP CEO who also is the chief scientist for ORMP also pumped both EMIS and GNBT years ago and look at them now .15 and .05 cent range. That is the real dirt on oral insulin and probably one reason why Warren Buffet wouldn't invest in ORMP ever.
ridiculous, she's writting ORMP since more than a year now, she bought in this company at around 5$ and looks at the share price right now, she made alot of money already. Your MNKD will go down big time 2 set back and more to come . Nobody dares to touch it, even Jim Cramer said MNKD is too hot to touch .
I'm long MNKD and Happy that Cramer ducked a opinion with a non answer "too hot to handle" because his minion Adam Fuerstein panned MNKD with not one solid scientific reason except past issues long resolved. Meanwhile endorsements from the Juvenile diabetes association and other universities pour in backing MNKD. ORMP may find its place in a couple of years after the long FDA 3 process but for now MNKD's Afrezza is set to change the diabetes landscape and at 5.45 its a screaming buy that will cash in less than two months.